IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification

1 month ago

CAESAREA, Israel, Nov. 14, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (the "Company"), developer of minimally-invasive cryoablation technology that…

Volta Labs and New England Biolabs Partner to Expand Automated NGS Library Preparation on the Callisto Platform

1 month ago

BOSTON, Nov. 14, 2025 /PRNewswire/ -- Volta Labs, a leader in automation for genomics, and New England Biolabs® (NEB®), a world-renowned…

Tiger BioSciences Headlines IPAWS Conference, Showcases Extensive Clinical Data in Wound Care

1 month ago

CONSHOHOCKEN, Pa., Nov. 14, 2025 /PRNewswire/ -- Tiger BioSciences proudly served as the headline sponsor of the International Post-Acute Wound Care…

Masimo Issues Statement on California Jury Verdict Finding Patent Infringement by Apple and Awarding Masimo $634 Million in Damages

1 month ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today issued the following statement in response to the jury verdict announced in the U.S.…

Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights

1 month ago

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing PHILADELPHIA, PENNSYLVANIA…

ADM Tronics Reports Second Quarter of Fiscal Year 2026 Results

1 month ago

NORTHVALE, NJ / ACCESS Newswire / November 14, 2025 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer…

Tivic Reports Third Quarter 2025 Financial Results

1 month ago

Continues Execution of Strategic Transformation and Advancement of Biologics Pipeline FREMONT, CA / ACCESS Newswire / November 14, 2025 /…

Ensysce Biosciences Reports Third Quarter 2025 Financial Results

1 month ago

~ Third Quarter Highlighted by Initiation of Phase 3 Study of PF614, Underscoring Progress Toward Market Readiness and Commitment to…

CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results

1 month ago

SOUTH SAN FRANCISCO, CA / ACCESS Newswire / November 14, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company…

Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

1 month ago

- Dermata announced a strategic pivot to develop and commercialize over-the-counter (OTC) skin care treatments -- Dermata plans to launch…